Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Inside Tract - Islets for the Weary
Inside Tract Spring 2012
Islets for the Weary
Date: March 1, 2012
A new autotransplant program shows how life can resume without a pancreas.
“We care for all chronic pancreatitis patients,” says Vikesh Singh, who, with Martin Makary, runs the new islet autotransplant program. Last month they treated a woman who came to Hopkins in pain despite a prior Whipple surgery. “We removed her remaining pancreas,” Makary adds, “infused her own islets, and she’s feeling much better.”
This past summer, Hopkins began offering islet autotransplants for men and women with intractable chronic pancreatitis. It’s a path worth walking, say the patients who, despite removal of the entire pancreas, can now produce insulin.
The new capability makes The Johns Hopkins Hospital the Northeast’s high-volume center for islet autotransplants.
“For certain patients, a total pancreatectomy is their last option to escape the lasting, severe pain of chronic pancreatitis,” says Vikesh Singh, medical director of the islet autotransplant program. “And while we can indeed replace digestive enzymes that the body no longer secretes without a pancreas, compensating for the lost islets is another story.” The “brittle” diabetes that can result resists control.
Fortunately, recent research has refined the ability to isolate living islets from a damaged pancreas. The same goes for tactics that raise their survival once they’re extracted and transferred into a patient’s liver.
What prompted the new Hopkins effort? “We found ourselves with a happy confluence of expertise and support,” says Singh, gastroenterologist for the team that includes pancreatic surgeons, transplant surgeons, cell biologists, endocrinologists and pain specialists.
Choosing patients for both pancreatectomy and transplant is complicated.
In his role as “selector,” Singh first winnows patients based on anatomy: “We consider those with small- rather than large-duct pancreatitis, as they have fewer options.”
But he also must carefully assess how advanced the disease is—no simple matter when biopsy of the pancreas, with its risks, is rarely an option.
“There’s a fine balance point,” Singh says. “You want to remove a pancreas because there’s pain. But you hesitate to take out an organ with mostly good function. Yet if you wait until the pain requires narcotics, is that too late? The natural history of chronic pancreatitis means islets die. Wait too long and there’s nothing to transplant. In the long run, we do a lot of evaluating, most of it as a team.”
“We bring a rich experience to treating pancreatitis,” says pancreatic surgeon Martin Makary, the program’s surgical director. That includes the benefits of doing a high volume of pancreatectomies and other surgeries on the organ.
Makary and his surgical team perform some 400 pancreas operations a year, more than any hospital worldwide. Having introduced a laparoscopic version of the Whipple procedure to Hopkins, he’s readying a minimally invasive total pancreatectomy to pair with the islet transplants.
Once a pancreas is removed, Makary explains, the transplant surgery team performs “a massive laboratory endeavor”—all totally within the OR—to retrieve its islets. A good harvest is crucial, as transplanted islet cells no longer reproduce. Once Makary injects them via catheter into the liver, they’re free to set up shop.
As for the other patients, those with chronic large-duct pancreatitis? They’re also treated at Hopkins’ Pancreatitis Center, Singh reassures. They can opt for less-major surgery to improve duct drainage and/or remove scar tissue, thus improving function and slowing decline.
“A lot of our patients whose lives were on hold are able to return to their jobs,” Singh says. “It made my day when a patient called to tell me, I ate a grilled cheese sandwich for the first time in years!”